“PacBio’s mission is to enable the promise of genomics to better human health,” said Christian Henry, President and Chief Executive Officer of PacBio. “China’s regulatory approval of Sequel II CNDx ...
MENLO PARK, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced a significant advancement for ...
PacBio's Advanced Sequencing Solutions Enable Breakthrough in Understanding Rare Mendelian Condition
PacBio announced its involvement in a groundbreaking study published in Nature Genetics, which utilized its advanced sequencing technology to explore the genetic basis of a rare Mendelian condition in ...
StockStory.org on MSN
PacBio (NASDAQ:PACB) Reports Sales Below Analyst Estimates In Q3 Earnings
Genomics company Pacific Biosciences of California (NASDAQ:PACB) in Q3 CY2025, with sales falling 3.8% year on year to $38.44 ...
GAAP net loss for the third quarter of 2025 was $38.0 million, compared to $60.7 million for the third quarter of 2024. Non-GAAP net loss for the third quarter of 2025 was $36.8 million, compared to ...
MENLO PARK, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced its entry into the ...
Olga Anczukow and Ryan Englander discuss how transcriptome splicing affects immune system function in lung cancer.
Organization's 6,000-genome effort will power global ALS research through detailed long-read sequencing data made freely available to scientists worldwide ALS is a progressive neurodegenerative ...
TipRanks on MSN
Pacific Biosciences Reports Q3 2025 Financial Results
Pacific Biosciences ( ($PACB) ) has released its Q3 earnings. Here is a breakdown of the information Pacific Biosciences presented to its ...
Pacific Biosciences is reducing both headcount and spending across its DNA sequencing business, in the face of escalating global tariffs and threats to federal biomedical research grants. Looking to ...
MENLO PARK, Calif., Oct. 11, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the availability of PacBio WGS ...
The National Institute on Aging’s Long Life Family Study (LLFS) selected PacBio technology to generate genomic and epigenomic data from as many as 7,800 participants. The effort will rely on PacBio’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback